IMMUNE PRIMING WITH NIVOLUMAB FOLLOWED BY NIVOLUMAB & RITUXIMAB IN 1ST LINE TREATMENT OF FOLLICULAR LYMPHOMA: THE PHASE 2 1ST FLOR STUDY

EA Hawkes, ST Lee, G Chong, M Gilbertson, A Grigg, L Churilov, T Fancourt, C Keane, D Ritchie, R Koldej, R Agarwal, K Manos, C Smith, K Houdyk, J Hawking, A Barraclough